These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27225591)

  • 1. Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy.
    Millino C; Maretto I; Pacchioni B; Digito M; De Paoli A; Canzonieri V; D'Angelo E; Agostini M; Rizzolio F; Giordano A; Barina A; Rajendran S; Esposito G; Lanfranchi G; Nitti D; Pucciarelli S
    J Cell Physiol; 2017 Feb; 232(2):426-435. PubMed ID: 27225591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
    D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
    Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
    Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.
    D'Angelo E; Zanon C; Sensi F; Digito M; Rugge M; Fassan M; Scarpa M; Pucciarelli S; Nitti D; Agostini M
    J Clin Pathol; 2018 Apr; 71(4):344-350. PubMed ID: 28870889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-519b-3p promotes responsiveness to preoperative chemoradiotherapy in rectal cancer patients by targeting ARID4B.
    Luo J; Liu L; Zhou N; Shen J; Sun Q; Zhu Y; Chen M
    Gene; 2018 May; 655():84-90. PubMed ID: 29477868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.
    Caramés C; Cristóbal I; Moreno V; del Puerto L; Moreno I; Rodriguez M; Marín JP; Correa AV; Hernández R; Zenzola V; Hernández T; León A; Martín JI; Sánchez-Fayos P; García-Olmo D; Rojo F; Goel A; Fernandez-Aceñero MJ; García-Foncillas J
    Int J Colorectal Dis; 2015 Jul; 30(7):899-906. PubMed ID: 25953218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
    Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
    Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer.
    Cho E; Park IJ; Yeom SS; Hong SM; Lee JB; Kim YW; Kim MJ; Lim HM; Lim SB; Yu CS; Kim JC
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):834-842. PubMed ID: 31419511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    Campayo M; Navarro A; Benítez JC; Santasusagna S; Ferrer C; Monzó M; Cirera L
    PLoS One; 2018; 13(11):e0206542. PubMed ID: 30388154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Zhu Z; Wang X; Etxart A; Park Y; Bujanda L; Park IJ; Goel A
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34913022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
    Liu H; Zhang Z; Zhen P; Zhou M
    J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
    Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
    Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.
    Ferrando L; Cirmena G; Garuti A; Scabini S; Grillo F; Mastracci L; Isnaldi E; Marrone C; Gonella R; Murialdo R; Fiocca R; Romairone E; Ballestrero A; Zoppoli G
    PLoS One; 2020; 15(2):e0226595. PubMed ID: 32023246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Preoperative Chemoradiotherapy on the Likelihood of Sphincter Preservation Surgery in Locally Advanced Distal Rectal Cancer: A Longitudinal Study Based on Pelvic Magnetic Resonance Imaging.
    Ihn MH; Kim YH; Kim DW; Oh HK; Lee SY; Park JT; Son IT; Park JH; Lee YJ; Kim JW; Lee KW; Kim JH; Shin E; Lee HS; Ahn S; Kang SB
    Ann Surg Oncol; 2015 Jul; 22(7):2159-67. PubMed ID: 25503346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.